[1] |
蒋金玲, 周尘飞, 王超, 等. 2022年度胃癌研究和诊疗新进展[J]. 中国癌症杂志, 2023, 33(4):303-314.
|
|
JIANG J L, ZHOU C F, WANG C, et al. New progress in research and diagnosis of gastric cancer in 2022[J]. Chinese Journal of Cancer, 2023, 33(4):303-314. doi:10.19401/j.cnki.1007-3639.2023.04.001.
|
[2] |
朱进华, 冯祥, 华召来, 等. 胃癌高发地区40-69岁人群幽门螺旋杆菌感染与胃部疾病关联分析[J]. 中华肿瘤防治杂志, 2023, 13(1):765-772.
|
|
ZHU J H, FENG X, HUA Z L, et al. Analysis of the association between helicobacter pylori infection and gastric diseases in 40-69 year old population in high incidence areas of gastric cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2023, 13(1):765-772. doi:10.16073/j.cnki.cjcpt.2023.13.01.
|
[3] |
戚利坤, 王巍. 肿瘤坏死因子α诱导蛋白6在胃癌组织中的表达及其与预后的关系[J]. 天津医药, 2022, 50(3):300-304.
|
|
QI L K, WANG W. The expression level of tumor necrosis factor-α induced protein 6(TNFαIP6)gastric cancer and its relationship with prognosis[J]. Tianjin Med J, 2022, 50(3):300-304. doi:10.11958/20211402.
|
[4] |
李剑锋, 蒋军林. miRNA-107、肿瘤坏死因子α及血清胃蛋白酶原Ⅰ/Ⅱ联合检查对胃癌的诊断价值[J]. 国际老年医学杂志, 2023, 44(5):597-600.
|
|
LI J F, JIANG J L. The value of combined detection of miRNA-107,TNF-α and serum pepsinogenⅠ/Ⅱ in the diagnosis of gastrie cancer[J]. Int J Gerialr, 2023, 44(5):597-600. doi:10.3969/j.issn.1674-7593.2023.05.017.
|
[5] |
HU H T, AI X, LU M, et al. Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer[J]. Exp Cell Res, 2019, 384(2):1-7. doi:10.1016/j.yexcr.2019.111652.
|
[6] |
LIU Q, YANG C, WANG S, et al. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression[J]. Cell Commun Signal, 2020, 18(1):51-70. doi:10.1186/s12964-020-00557-2.
|
[7] |
中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜专业委员会. 中国早期胃癌筛查及内镜诊治共识意见(2014年,长沙)[J]. 中华消化杂志, 2014, 34(7):433-448.
|
|
Chinese Society of Gastrointestinal Endoscopy,Tumor Endoscopy Committee of the Chinese Anti-Cancer Association. Consensus opinion on early gastric cancer screening and endoscopic diagnosis and treatment in China (2014, Changsha)[J]. Chinese Journal of Digestion,2014, 34(7):433-448. doi:10.3969/j.issn.1008-7125.2014.07.006.
|
[8] |
韩占波, 王国平, 董建路. 消化内科疾病诊断标准[M]. 北京: 科学技术文献出社, 2009:183-185.
|
|
HAN Z B, WANG G P, DONG J L. Diagnostic criteria for digestive diseases[M]. Beijing: Science and Technology Literature Publishing House, 2009:183-185.
|
[9] |
郭辉, 程广坤, 张晓雪, 等. 幽门螺旋杆菌感染与胃癌患者血清IL-1β、IL-8、IL-32的关系[J]. 海南医学, 2020, 31(18):2326-2329.
|
|
GUO H, CHENG G K, ZHANG X X, et al. Relationship between helicobacter pylori infeetion and serum IL-1β,IL-8,IL-32 in patients with gastric cancer[J]. Hainan Med J, 2020, 31(18):2326-2329. doi:10.3969/j.issn.1003-6350.2020.18.004.
|
[10] |
CHEN Y, WANG B, ZHAO Y, et al. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer[J]. Nat Commun, 2024, 15(1):1657-1670. doi:10.1038/s41467-024-46043-y.
|
[11] |
薛倩, 刘鹏, 黄新春, 等. Hp阳性的早期胃癌患者肿瘤组织中miR-134和PBP1A的表达及其临床意义[J]. 国际消化病杂志, 2022, 42(1):54-58.
|
|
XUE Q, LIU P, HUANG X C, et al. Expression of miR-134 and PBP1A in tumor tissues of Hp-positive early gastric cancer patients and its clinical significance[J]. Int J Dig Dis, 2022, 42(1):54-58. doi:10.3969/j.issn.1673-7083.2022.01.012.
|
[12] |
刘旭初, 谭世运, 梁彬, 等. 血清CEA、CA72-4、CA19-9及胃蛋白酶原水平对胃癌早期诊断的临床价值[J]. 中国现代普通外科进展, 2022, 25(3):196-200.
|
|
LIU X C, TAN S Y, LIANG B, et al. Clinical value of serum levels of CEA,CA72-4,CA19-9 and pepsinogen in early diagnosis of gastric cancer[J]. Chin J Curr Adv Gen Surg, 2022, 25(3):196-200. doi:10.3969/j.issn.1009-9905.2022.03.006.
|
[13] |
CUI X, ZHANG H, CAO A, et al. Cytokine TNF-α promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3[J]. Cancer, 2020, 11(7):1800-1807. doi:10.7150/jca.39562.eCollection 2020.
|
[14] |
徐大洲, 孙运良, 靳卫权, 等. 早期胃癌术后感染患者TNF-α和DAO及IFABP与胃肠功能恢复的相关性[J]. 中华医院感染学杂志, 2022, 32(3):434-438.
|
|
XU D Z, SUN Y L, JIN W Q, et al. Correlation of serum TNF-α,DAO and IFABP levels with recovery ofgastrointestinal function in patients with postoperative infection of early gastrie cancer[J]. Chin J Nosocomiol, 2022, 32(3):434-438. doi:10.11816/cn.ni.2022-210475.
|
[15] |
查艳梅, 张军玉, 於薇, 等. TNF-α通过NF-κB信号通路调控宣威肺癌恶性生物学行为[J]. 肿瘤学杂志, 2021, 27(7):560-565.
|
|
ZHA Y M, ZHANG J Y, YU W, et al. TNF-α regulates Malignant biological behavior of xuanweilung cancer through NF-κB signal pathway[J]. Joumnal of Chinese Oncology, 2021, 27(7):560-565. doi:10.11735/j.issn.1671-170X.2021.07.B009.
|
[16] |
BOUNDER G, JOUIMYI M R, BOURA H, et al. Associations of the -238(G/A)and -308(G/A)TNF-α promoter polymorphisms and TNF-α serum levels with the susceptibility to gastric precancerous lesions and gastric cancer related to helicobacter pylori infection in a moroccan population[J]. Asian Pac J Cancer Prev, 2020, 21(6):1623-1629. doi:10.31557/APJCP.2020.21.6.1623.
|
[17] |
ZHOU Q, WU X, WANG X, et al. The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis[J]. Oncogene, 2020, 39(7):1414-1428. doi:10.1038/s41388-019-1078-x.
|
[18] |
高英, 刘宏飞, 杨君寅, 等. 血清G-17、PG Ⅰ、PG Ⅱ及PDCD5蛋白在胃癌前状态及早期胃癌诊断中的应用[J]. 中国基层医药, 2023, 30(12):1808-1813.
|
|
GAO Y, LIU H F, YANG J Y, et al. Application of serum gastrin 17,pepsinogen I,pepsinogen II,and programmed cell death protein 5 protein in the identification of gastric precancerous state and diagnosis of early gastric cancer[J]. Chinese Journal of Primary Medicine and Pharmacy, 2023, 30(12):1808-1813. doi:10.3760/cma.j.cn341190-20230423-00323.
|
[19] |
WANG G, XU B, SHI F, et al. Protective effect of methane-rich saline on acetic acid-induced ulcerative colitis via blocking the TLR4/NF-κB/MAPK pathway and promoting IL-10/JAK1/STAT3-mediated anti-inflammatory response[J]. Oxid Med Cell Longev, 2019, 2019:7850324. doi:10.1155/2019/7850324.
|
[20] |
KINDLUND B, SJOLING A, YAKKALA C, et al. CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β[J]. Gastric Cancer, 2017, 20(1):116-125. doi:10.1007/s10120-015-0591-z.
|
[21] |
CHEN L, SHI Y, ZHU X, et al. IL-10 secreted by cancer-associated macrophages regulates proliferation and invasion in gastric cancer cells via c-Met/STAT3 signaling[J]. Oncol Rep, 2019, 42(2):595-604. doi:10.3892/or.2019.7206.
|
[22] |
蔡沾焕, 陈升, 王艳良. 胃癌血清miR-375和CHSY1表达与幽门螺杆菌感染的相关性研究[J]. 局解手术学杂志, 2023, 32(7):604-607.
|
|
CAl Z H, CHEN S, WANG Y L. Correlation between serum miR-375 and CHSY1 expression and helicobacter pylori infection in gastric cancer[J]. Jreg Anat Oper Surg, 2023, 32(7):604-607. doi:10.11659/jjssx.10E022011.
|
[23] |
ZHU L, HUANG Y, LI H, et al. Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment[J]. Appl Microbiol Biotechnol, 2022, 106(12):4375-4385. doi:10.1007/s00253-022-12011-z.
|
[24] |
ALIPOUR M. Molecular mechanism of Helicobacter pylori-induced gastric cancer[J]. J Gastrointest Cancer, 2021, 52(1):23-30. doi:10.1007/s12029-020-00518-5.
|